Chang‐Jun Tan

Downstaging and Resection of Initially Unresectable Hepatocellular Carcinoma with Tyrosine Kinase Inhibitor and Anti-PD-1 Antibody Combinations

Xiao‐Dong Zhu, Cheng Huang, Ying‐Hao Shen et al. · Liver Cancer · 2021 · 237 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma: [RETRACTED] #

Dousheng Bai, Zhi Dai, Jian Zhou et al. · Hepatology · 2008 · 95 citations · Full text

Life Sciences, Oncology, Metastasis +8

Organ specific responses to first-line lenvatinib plus anti-PD-1 antibodies in patients with unresectable hepatocellular carcinoma: a retrospective analysis

Cheng Huang, Xiao‐Dong Zhu, Ying‐Hao Shen et al. · Biomarker Research · 2021 · 76 citations · Full text

Medicine, Oncology, Pharmacology +12

Plasma MicroRNA, a Potential Biomarker for Acute Rejection After Liver Transplantation

Jie Hu, Zheng Wang, Chang‐Jun Tan et al. · Transplantation · 2013 · 66 citations

Life Sciences, Immunology, Molecular Biology +17

Activation of PI3K/AKT and MAPK Pathway through a PDGFRβ-Dependent Feedback Loop Is Involved in Rapamycin Resistance in Hepatocellular Carcinoma

Quan‐Lin Li, Fangming Gu, Zheng Wang et al. · PLoS ONE · 2012 · 61 citations · Full text

Medicine, Oncology, Pharmacology +17